Search for Clinical Trial Results

Sponsored By

Gout - 56 Studies Found

Status Study
Recruiting Study Name: Reverse Transcriptase Inhibitors in AGS
Condition: Aicardi-Goutières Syndrome (AGS)
Date: 2015-01-15
Interventions: Drug: Reverse transcriptase inhibitors: Zidovudine, Lamivudine, Abacavir Oral Solution (syrup) or Tablet
Completed Study Name: A Study of AGS-1C4D4 in Pancreatic Cancer Subjects Previously Treated in Protocol 2008002
Condition:
  • Pancreatic Cancer
  • Carcinoma, Pancreatic Ductal
  • Pancreatic
    Date: 2012-05-29
    Interventions:
    • Biological: AGS-1C4D4 Intraven
Completed Study Name: A Study of AGS-1C4D4 Given in Combination With Gemcitabine in Subjects With Metastatic Pancreatic Cancer
Condition:
  • Carcinoma, Pancreatic Ductal
  • Pancreatic Cancer
  • Pancreatic
    Date: 2009-05-13
    Interventions:
    • Biological: AGS-1C4D4 IV infus
Completed Study Name: AGS-1C4D4 in Patients With Advanced Hormone Refractory Prostate Cancer
Condition: Prostate Cancer
Date: 2007-08-20
Interventions: Drug: AGS-1C4D4 IV
Completed Study Name: Celebrex In Acute Gouty Arthritis Study
Condition: Arthritis, Gouty
Date: 2007-10-24
Interventions:
  • Drug: Indomethacin indomethaci
Recruiting Study Name: A Study to Evaluate Efficacy and Safety of Anakinra in the Treatment of Acute Gouty Arthritis
Condition: Acute Gouty Arthritis
Date: 2016-12-13
Interventions:
  • Drug: Anakinra 100 mg 100 mg/0
Completed Study Name: Safety and Efficacy of Canakinumab Prefilled Syringes in Frequently Flaring Acute Gouty Arthritis Patients
Condition: Acute Gouty Arthritis
Date: 2011-05-16
Interventions:
  • Drug: Canakinumab pre-filled syringe

Completed Study Name: Long-Term Safety and Tolerability of Canakinumab Prefilled Syringes in Frequently Flaring Acute Gouty Arthritis Patients
Condition: Acute Gouty Arthritis
Date: 2011-08-30
Interventions: Drug: Canakinumab 150mg in prefilled syringe Canakinumab 150mg in prefilled syringe will be given in a s
Completed Study Name: Efficacy and Safety of a Single Dose of Canakinumab (ACZ885) in Hospitalized Patients With Acute Gout
Condition: Arthritis, Gouty
Date: 2008-04-18
Interventions:
  • Biological: canakinumab 10 mg/
Withdrawn Study Name: Canakinumab in the Treatment of Gouty Arthritis Flare(s) and Prevention of New Flares in Patients With Chronic Kidney Disease
Condition: Acute Gouty Arthritis
Date: 2012-05-03
Interventions:
  • Drug: ACZ885 Canakinumab 150 m
Next >>>